Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Bone Marrow Transplantation (3)
Blood Cancer Journal (2)
Leukemia (1)
Nature Medicine (1)
Nature Cancer (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (6)
Correspondence (2)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Diseases
Health care
Immunology
Medical research

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–8 of 8 results

Advanced filters: Author: Parveen Shiraz Clear advanced filters

Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trial

In this phase 2 ZUMA-14 clinical trial, Strati et al. reported the safety and efficacy of axicabtagene ciloleucel plus rituximab in adult participants with chemorefractory large B cell lymphomas and compared the results with previous findings from ZUMA-1 cohort 1.

Paolo Strati
Lori Leslie
Krish Patel
ResearchOpen Access05 Jan 2026
Nature Cancer

P: 1-12
CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results

Liora M. Schultz
Nikeshan Jeyakumar
Lori Muffly
Research15 Mar 2024
Leukemia

Volume: 38, P: 963-968
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Bispecific CAR T cells targeting CD19 and CD22 exhibit clinical activity and low toxicity in patients with large B cell lymphoma and B cell acute lymphoblastic leukemia, with relapses associated with loss of CD19 but not CD22.

Jay Y. Spiegel
Shabnum Patel
David B. Miklos
ResearchOpen Access26 Jul 2021
Nature Medicine

Volume: 27, P: 1419-1431
Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myeloma

Christopher Lemieux
Lori S. Muffly
Surbhi Sidana
Research11 Aug 2020
Bone Marrow Transplantation

Volume: 56, P: 368-375
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohort

Shlomo Elias
Samantha Brown
Boglarka Gyurkocza
CorrespondenceOpen Access25 Nov 2025
Blood Cancer Journal

Volume: 15, P: 1-5
Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myeloma

Surbhi Sidana
Andriyana K. Bankova
Judith A. Shizuru
ResearchOpen Access09 Oct 2024
Blood Cancer Journal

Volume: 14, P: 1-10
Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma

Christopher Lemieux
Lori S. Muffly
Surbhi Sidana
Research23 Jun 2021
Bone Marrow Transplantation

Volume: 56, P: 2664-2671
Belumosudil combination therapy for chronic graft-versus-host-disease in real-world clinical practice

Michelle M. Chin
John S. Tamaresis
Sally Arai
CorrespondenceOpen Access18 Nov 2024
Bone Marrow Transplantation

Volume: 60, P: 393-395